BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20739385)

  • 1. DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Shufelt C; Bretsky P; Almeida CM; Johnson BD; Shaw LJ; Azziz R; Braunstein GD; Pepine CJ; Bittner V; Vido DA; Stanczyk FZ; Bairey Merz CN
    J Clin Endocrinol Metab; 2010 Nov; 95(11):4985-92. PubMed ID: 20739385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly Swedish men.
    Ohlsson C; Labrie F; Barrett-Connor E; Karlsson MK; Ljunggren O; Vandenput L; Mellström D; Tivesten A
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4406-14. PubMed ID: 20610590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: A report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.
    Linke SE; Rutledge T; Johnson BD; Vaccarino V; Bittner V; Cornell CE; Eteiba W; Sheps DS; Krantz DS; Parashar S; Bairey Merz CN
    Arch Gen Psychiatry; 2009 May; 66(5):499-507. PubMed ID: 19414709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women.
    Wessel TR; Arant CB; Olson MB; Johnson BD; Reis SE; Sharaf BL; Shaw LJ; Handberg E; Sopko G; Kelsey SF; Pepine CJ; Merz NB
    JAMA; 2004 Sep; 292(10):1179-87. PubMed ID: 15353530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-rated versus objective health indicators as predictors of major cardiovascular events: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
    Rutledge T; Linke SE; Johnson BD; Bittner V; Krantz DS; Whittaker KS; Eastwood JA; Eteiba W; Cornell CE; Pepine CJ; Vido DA; Olson MB; Shaw LJ; Vaccarino V; Bairey Merz CN
    Psychosom Med; 2010 Jul; 72(6):549-55. PubMed ID: 20410246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Dehydroepiandrosterone Sulfate and Cardiovascular Disease Risk in Older Men and Women.
    Jia X; Sun C; Tang O; Gorlov I; Nambi V; Virani SS; Villareal DT; Taffet GE; Yu B; Bressler J; Boerwinkle E; Windham BG; de Lemos JA; Matsushita K; Selvin E; Michos ED; Hoogeveen RC; Ballantyne CM
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4304-27. PubMed ID: 32785663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory.
    Sharaf B; Wood T; Shaw L; Johnson BD; Kelsey S; Anderson RD; Pepine CJ; Bairey Merz CN
    Am Heart J; 2013 Jul; 166(1):134-41. PubMed ID: 23816032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comorbid depression and anxiety symptoms as predictors of cardiovascular events: results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
    Rutledge T; Linke SE; Krantz DS; Johnson BD; Bittner V; Eastwood JA; Eteiba W; Pepine CJ; Vaccarino V; Francis J; Vido DA; Merz CN
    Psychosom Med; 2009 Nov; 71(9):958-64. PubMed ID: 19834049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE).
    Thurston RC; Johnson BD; Shufelt CL; Braunstein GD; Berga SL; Stanczyk FZ; Pepine CJ; Bittner V; Reis SE; Thompson DV; Kelsey SF; Sopko G; Bairey Merz CN
    Menopause; 2017 Feb; 24(2):126-132. PubMed ID: 27676638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation.
    Shaw LJ; Bairey Merz CN; Azziz R; Stanczyk FZ; Sopko G; Braunstein GD; Kelsey SF; Kip KE; Cooper-Dehoff RM; Johnson BD; Vaccarino V; Reis SE; Bittner V; Hodgson TK; Rogers W; Pepine CJ
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1276-84. PubMed ID: 18182456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the National Institutes of Health, National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Shaw LJ; Merz CN; Bittner V; Kip K; Johnson BD; Reis SE; Kelsey SF; Olson M; Mankad S; Sharaf BL; Rogers WJ; Pohost GM; Sopko G; Pepine CJ;
    J Womens Health (Larchmt); 2008 Sep; 17(7):1081-92. PubMed ID: 18774893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-sponsored WISE study.
    Rutledge T; Reis SE; Olson MB; Owens J; Kelsey SF; Pepine CJ; Mankad S; Rogers WJ; Merz CN; Sopko G; Cornell CE; Sharaf B; Matthews KA; Vaccarino V
    Arch Gen Psychiatry; 2006 Aug; 63(8):874-80. PubMed ID: 16894063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low plasma DHEA-S increases mortality risk among male hemodialysis patients.
    Hsu HJ; Yen CH; Chen CK; Hsu KH; Hsiao CC; Lee CC; Wu IW; Sun CY; Chou CC; Hsieh MF; Chen CY; Hsu CY; Tsai CJ; Wu MS
    Exp Gerontol; 2012 Dec; 47(12):950-7. PubMed ID: 22974561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Johnson BD; Kip KE; Marroquin OC; Ridker PM; Kelsey SF; Shaw LJ; Pepine CJ; Sharaf B; Bairey Merz CN; Sopko G; Olson MB; Reis SE;
    Circulation; 2004 Feb; 109(6):726-32. PubMed ID: 14970107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Past oral contraceptive use and angiographic coronary artery disease in postmenopausal women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.
    Merz CN; Johnson BD; Berga S; Braunstein G; Reis SE; Bittner V;
    Fertil Steril; 2006 May; 85(5):1425-31. PubMed ID: 16600235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.
    Shufelt CL; Johnson BD; Berga SL; Braunstein GD; Reis SE; Bittner V; Yang Y; Pepine CJ; Sharaf BL; Sopko G; Kelsey SF; Merz CN;
    Menopause; 2011 Sep; 18(9):943-50. PubMed ID: 21532511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.
    Pepine CJ; Anderson RD; Sharaf BL; Reis SE; Smith KM; Handberg EM; Johnson BD; Sopko G; Bairey Merz CN
    J Am Coll Cardiol; 2010 Jun; 55(25):2825-32. PubMed ID: 20579539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study.
    Bairey Merz CN; Johnson BD; Sharaf BL; Bittner V; Berga SL; Braunstein GD; Hodgson TK; Matthews KA; Pepine CJ; Reis SE; Reichek N; Rogers WJ; Pohost GM; Kelsey SF; Sopko G;
    J Am Coll Cardiol; 2003 Feb; 41(3):413-9. PubMed ID: 12575968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Johnson BD; Shaw LJ; Buchthal SD; Bairey Merz CN; Kim HW; Scott KN; Doyle M; Olson MB; Pepine CJ; den Hollander J; Sharaf B; Rogers WJ; Mankad S; Forder JR; Kelsey SF; Pohost GM;
    Circulation; 2004 Jun; 109(24):2993-9. PubMed ID: 15197152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight cycling and cardiovascular outcome in women with suspected ischemia: A report from the NHLBI-sponsored WISE Study.
    Bairey Merz CN; Olson MB; Kelsey SF; Bittner V; Reis SE; Reichek N; Handberg E
    PLoS One; 2018; 13(12):e0207223. PubMed ID: 30507935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.